AU6331199A - Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders - Google Patents
Oxazolidine derivatives for the treatment and prevention of metabolic bone disordersInfo
- Publication number
- AU6331199A AU6331199A AU63311/99A AU6331199A AU6331199A AU 6331199 A AU6331199 A AU 6331199A AU 63311/99 A AU63311/99 A AU 63311/99A AU 6331199 A AU6331199 A AU 6331199A AU 6331199 A AU6331199 A AU 6331199A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- bone disorders
- metabolic bone
- oxazolidine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98118522 | 1998-09-30 | ||
| EP98118522 | 1998-09-30 | ||
| PCT/EP1999/007253 WO2000018745A1 (en) | 1998-09-30 | 1999-09-30 | Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6331199A true AU6331199A (en) | 2000-04-17 |
Family
ID=8232724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63311/99A Abandoned AU6331199A (en) | 1998-09-30 | 1999-09-30 | Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6331199A (en) |
| WO (1) | WO2000018745A1 (en) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794532A (en) * | 1972-01-26 | 1973-07-25 | Boehringer Sohn Ingelheim | NEW 3-HYDROXYMETHYL-5-BENZYLIDENE-AZOLIDINONES AND PROCESS FOR MAKING THEM |
| US4367234A (en) * | 1980-07-28 | 1983-01-04 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
| US4430337A (en) * | 1982-06-23 | 1984-02-07 | Pfizer Inc. | Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity |
| IE940525L (en) * | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
| WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
| US5498621A (en) * | 1992-05-01 | 1996-03-12 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| TW268952B (en) * | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| US5614544A (en) * | 1993-09-14 | 1997-03-25 | Takeda Chemical Industries, Ltd. | Oxazolidinedione derivatives and their use |
| US5468762A (en) * | 1994-05-18 | 1995-11-21 | American Home Products Corporation | Azolidinediones as antihyperglycemic agents |
| JPH09136877A (en) * | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | Heterocyclic compound, its production and use thereof |
| EP0783888A1 (en) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| GB9614402D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
-
1999
- 1999-09-30 WO PCT/EP1999/007253 patent/WO2000018745A1/en not_active Ceased
- 1999-09-30 AU AU63311/99A patent/AU6331199A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000018745A1 (en) | 2000-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU4060599A (en) | Pharmaceutical composition for treating or preventing sleep disorders | |
| AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
| EP1143956A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
| IL143921A0 (en) | Compositions for the treatment and prevention of tumors and tumor-related disorders | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| AU2209697A (en) | Fluorocarbons for diagnosis and treatment of articular disorders | |
| AU1742200A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| AU2463099A (en) | Gabapentin and its derivatives for the treatment of muscular and skeletal pain | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
| AU6330999A (en) | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU2058697A (en) | Treatment of sleep disorders | |
| AU6330799A (en) | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders | |
| AU9551298A (en) | Use of coumarin derivatives for the treatment of digestive tract disorders | |
| AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
| AU6331099A (en) | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders | |
| AU7106300A (en) | Treatment of skin disorders | |
| AU1878201A (en) | Composition for the treatment of damaged tissue | |
| AU5699396A (en) | Compositions for the treatment of skin conditions | |
| CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |